| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-10 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |